IN8bio, Inc.

INAB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$30-$30-$29-$15
Dep. & Amort.$3$3$1$1
Deferred Tax$0$0-$4-$1
Stock-Based Comp.$5$0$3$2
Change in WC-$1-$0-$0-$2
Other Non-Cash$0$4$4$1
Operating Cash Flow-$24-$23-$24-$14
Investing Activities
PP&E Inv.-$0-$1-$4-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0$0$0
Investing Cash Flow-$0-$1-$4-$0
Financing Activities
Debt Repay.-$1-$1-$1-$1
Stock Issued$10$28$10$36
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$5$0$0-$3
Financing Cash Flow$14$27$9$33
Forex Effect$0-$0$0$0
Net Chg. in Cash-$10$3-$19$19
Supplemental Information
Beg. Cash$22$18$37$18
End Cash$11$21$18$37
Free Cash Flow-$24-$24-$28-$14
IN8bio, Inc. (INAB) Financial Statements & Key Stats | AlphaPilot